|Variable||Adjusted Odds Ratio|
|STEMI (vs. SA)||1.87 (1.04–3.36)||0.04|
|NSTE-ACS (vs. SA)||2.07 (1.26–3.40)||0.004|
|Thrombus at baseline||1.79 (1.12–2.84)||0.01|
|Total stent length (per 1-mm increase)||1.03 (1.02–1.03)||<0.0001|
|Cangrelor at randomization (vs. clopidogrel)||0.65 (0.42–1.00)||0.048|
*Candidate variables included in the model: current smoker, diagnosis at presentation (stable angina vs. NSTE-ACS vs. STEMI), number of PCI vessels, DES versus BMS used, total stent length, TIMI flow at baseline (3 vs. 0-1-2), presence of thrombus at baseline, U.S. versus non-U.S. site, cangrelor infusion.
BMS = bare-metal stent(s); DES = drug-eluting stent(s); SA = stable angina; other abbreviations as in Tables 1 and 2.